Owens & Minor (OMI)
(Delayed Data from NYSE)
$16.13 USD
-0.24 (-1.47%)
Updated Aug 26, 2024 04:00 PM ET
After-Market: $16.12 -0.01 (-0.06%) 5:54 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Owens & Minor (OMI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$19.21 | $28.00 | $15.50 | 17.35% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Owens & Minor comes to $19.21. The forecasts range from a low of $15.50 to a high of $28.00. The average price target represents an increase of 17.35% from the last closing price of $16.37.
Analyst Price Targets (7 )
Broker Rating
Owens & Minor currently has an average brokerage recommendation (ABR) of 2.86 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 2.86 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, two are Strong Buy, representing 28.57% of all recommendations. A month ago, Strong Buy represented 28.57%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/OMI.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 4 | 4 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.86 | 2.86 | 2.86 | 3.14 | 3.14 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/5/2024 | UBS | Kevin Caliendo | Strong Buy | Strong Buy |
7/19/2024 | Not Identified | Not Identified | Hold | Strong Buy |
6/25/2024 | Robert W. Baird & Co. | Eric W Coldwell | Hold | Hold |
6/25/2024 | Not Identified | Not Identified | Hold | Hold |
6/24/2024 | SVB Securities | Michael Cherny | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.86 |
ABR (Last week) | 2.86 |
# of Recs in ABR | 7 |
Average Target Price | $19.21 |
LT Growth Rate | 19.80% |
Industry | Medical - Products |
Industry Rank by ABR | 99 of 253 |
Current Quarter EPS Est: | 0.40 |